3
0AFC-HD AMS Life Science Co., Ltd. is a leading Japanese company specializing in the OEM (original equipment manufacturer) production of high-quality health foods and cosmetics. Headquartered in Shizuoka, the company operates as a comprehensive conglomerate aiming to complete all operations internally, from R&D and manufacturing to retail sales, in close collaboration with its academic research institute. In addition to its core healthcare and pharmaceutical sectors, the company has diversified into new areas including tourism, catering services, and real estate. Positioned for global growth, AFC-HD is actively pursuing international expansion in China and Vietnam, while running a Japanese language school to nurture foreign talent for local leadership roles to enhance its overall brand competitiveness.
Over the past three years, the group's revenue grew steadily from 25.5 billion yen in FY2023 to 32.6 billion yen in FY2025. The company aggressively targets strategic diversification into tourism and real estate alongside global expansion. Backed by strong FY2026 Q1 sales of 8.54 billion yen, full-year projections estimate revenue of 34.1 billion yen and operating profit of 2.54 billion yen. Net income has been upwardly revised to 1.54 billion yen, highlighting robust and steady earnings growth for the group.
The audio and written content of this podcast are intended to help listeners understand the general business conditions and publicly available information of major listed companies in Japan. They do not constitute investment advice, investment recommendations, or investment solicitations.
